“The research around psychedelics is just unreal; the potential of these medicines to completely transform the way that we provide mental health care and help people who really need big changes in their life is really exciting.” – Jack Swain
Jack Swain is Head of Clinical Operations at Mindbloom, a mental health and wellbeing company focused on psychedelic therapy. Before joining Mindbloom, Jack Swain was a healthcare consultant at The Chartis Group, where he worked with the Cleveland Clinic and Michigan Medicine.
To listen to Jack’s bonus interview and learn more about his own habits and routines, click here.
For more, explore the transcript of this episode.
Chapters in Part 1 of this interview:
- Jack’s background and intro to Mindbloom
- How healthcare today is broken, and why Jack is hopeful that it will improve
- What is psychedelic therapy?
- Why Mindbloom is focused on treating depression and anxiety
- Progress in the world of psychedelic medicine
- Examples of successful treatment with Mindbloom
- Mindblooms treatment model and clinicians
- Scaling a telemedicine company
- The history of psychedelic medicine
- The importance of journaling in mental health therapy
- The data and research coming from Mindbloom
Links from Part 1
- Connect with Jack Swain: Twitter | LinkedIn | Website
- Trying Ketamine To Treat Anxiety – Bustle
- ‘I Started Doing At-Home Guided Ketamine Treatments To Help With My Depression During Quarantine’ – Women’s Health
- Could the Embrace of Psychedelics Lead to a Mental-Health Revolution? – Vogue
- Dylan Beynon
- Casey Paleos, MD
- MAPS (Multidisciplinary Association for Psychedelic Studies
- Johns Hopkins
- Imperial College of London
- Kristin Arden
- Noom
- Accenture
- Teladoc
- Psychedelic Therapy 101: Journaling After Ketamine Treatment – Mindbloom
- Josh Clemente, Co-Founder of Levels: A Masterclass on Metabolic Health, The Next Frontier in Real-Time Health Optimization – Outlier Academy, Ep. 22
Terminology
- Psychedelic therapy
- Ketamine
- Value-based care
- Fee for service care
- CMS (Centers for Medicare & Medicaid Services)
- BDNF (Brain-derived neurotrophic factor)
- Neuroplasticity
- Default mode network
- PTSD (Post-traumatic stress disorder)
- OCD (Obsessive-Compulsive Disorder)
- Substance Use Disorder
- Alcohol Use Disorder
- MDMA (3,4-Methylenedioxymethamphetamine)
- Psilocybin
- FDA (U.S. Food and Drug Administration)
- Telemedicine
Books Recommended by Jack Swain
- How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence by Michael Pollan
- The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys by James Fadiman
- Stealing Fire: How Silicon Valley, the Navy SEALs, and Maverick Scientists Are Revolutionizing the Way We Live and Work by Steven Kotler and Jamie Wheal
Learn More About This Topic
Full of articles on the basics of psychedelic therapy, breathwork, journaling, and more, this blog is a great place to start.
The future of psychedelic-assisted psychotherapy
This 16-minute TED talk with Rick Doblin is a quick and entertaining intro to how psychedelics are being used with psychotherapy.
Why Psychedelics, Big in the 1960s, Are Drawing New Interest Now – Bloomberg
This quick summary from Bloomberg gives a basic overview of what psychedelics are and how they’re being used today.
Psychedelic Therapy with Roland Griffiths, PhD
This podcast episode with a professor of psychiatry and neuroscience at Johns Hopkins gives a great intro to the current research in psychedelic medicine.
Psychedelics, by David E. Nichols
For a full scientific deep dive into the world of psychedelic medicine, check out this article published in Pharmacol Review.
This new album by Jon Hopkins is released on Nov 12, 2021, but you can get a taste of the tunes with “Sit Around The Fire,” which was inspired by an expedition to Tayos Caves in Ecuador. A collaboration with Ram Dass, the song promises to take on a “new dimension entirely when brought into a psychedelic ceremony.”
